The study showed that 94% of all patients who correctly used the mask showed significant stabilisation and sometimes even improvement of the central diabetic maculopathy and vision with some patients seeing a reverse of their condition.
A Consultant Ophthalmic Surgeon at Ashford and St Peter’s NHS Hospital near London has found that treating the eyes of diabetic patients with the Noctura 400 eye mask might stabilise or even improve central diabetic retinopathy changes.
The North East & North Cumbria Academic Health Science Network have published an article celebrating Richard Kirk’s win at the BQ Emerging Entrepreneur Awards.
The West of England AHSN have posted a video about Noctura 400 on their Health Innovation channel to encourage collaborations with healthcare professionals.